Epigral · NSE: EPIGRAL · BSE: 543332

Q4 FY22 results · Jan–Mar 2022

Epigral reported revenue from operations of ₹498.80 crore and net profit of ₹99.09 crore for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations498.80——422.17+18.1%
Other income1.97——(0.30)Turned profit
Total income500.77——421.88+18.7%
Profit before tax144.20——108.90+32.4%
Net profit for the period99.09——69.73+42.1%
EPS, basic (₹)23.85——16.78+42.1%
Net margin (%)19.9—16.5
Standalone · ₹ crore
ItemQ4 FY22Q4 FY21YoYQ3 FY22QoQ
Revenue from operations498.80——422.17+18.1%
Other income1.97——(0.30)Turned profit
Total income500.77——421.88+18.7%
Profit before tax144.20——108.90+32.4%
Net profit for the period99.09——69.73+42.1%
EPS, basic (₹)23.85——16.78+42.1%
Net margin (%)19.9—16.5
Consolidated
Filed with BSE
25 Apr 2022, 16:23 IST
Board meeting
25 Apr 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
25 Apr 2022, 16:23 IST
Board meeting
25 Apr 2022
Period
01 Jan 2022 to 31 Mar 2022
Review status
Audited
Source
XBRL filing on BSE